Methods and systems for treating cell proliferation disorders with psoralen derivatives

US11452884B2 · kind B2 · utility

Assignees

• IMMUNOLIGHT, LLC · US
• Duke University · US

Inventors

• Eric J. Toone · Durham, US
• David Gooden · Durham, US
• Frederic A. Bourke, Jr. · Greenwich, US
• Harold Walder · Detroit, US

Key dates

• Filing date: Jan 22, 2018
• Grant date: Sep 27, 2022
• Expiry date: Jan 22, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61N2005/1098
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Psoralen compounds of compounds having formulae 1A-10A, 1B-10B, 1C-10C, 1D-10D, 1E-10E, 1F-10F, 1G-10G, and 1H-5H as shown in FIG. 1, and pharmaceutically acceptable salts thereof;